ACQUISITION OF A NEW EXPANSION AREA
The existing facility has been expanded through the acquisition of 6,000 sqm new area at the south border. Since then, ICROM has started a considerable capital investment program.

NEW HQ BUILDING AND R&D CENTER
With a surface of 1,000 sqm, the building hosts the Headquarters and a state-of-the-art R&D center.

ACQUISITION OF ANOTHER EXPANSION AREA
Another 3,500 sqm area has been acquired for further expansions at the south border.

NEW WAREHOUSES AND QUALITY UNIT BUILDING
With its 900 sqm surface, the new Warehouse building is equipped with semi-automatic shelves allocating over 1,600 pallets, while being integrated with company’s ERP and BAR code management. It also hosts classified dispensing rooms, with someones dedicated to diagnostic pharmaceutical dyes. The Quality Unit Building hosts the brand new and fully equipped Quality Control Laboratory as well as all Quality Unit Operations & offices. In Jan 2021 another 2,500 sqm area has been acquired on the East border.

CLINICAL SCALE PLANT
Equipped with 6 reactors from 100L to 400 L capacity, 3 of which in Hastelloy SS, 1 filter- dryer, 1 centrifuge and a static oven, the new GMP Clinical Scale production workshop is designed to meet the requirements of small scale APIs for clinical programs and it is designed to perform any type of chemical transformation from -80 to 200 °C.

THE CUBE
A new large scale production building which shall host up to 10 complete production lines shall be built starting from 2023 in order to meet ICROM capacity needs for its commercial APIs. Ancillary systems like a post-combustion burner, a new large Water Treatment Plant and Ecologic Areas will be installed on the surface acquired in 2021, to allow a safe management of the production wastes.